Zobrazeno 1 - 10
of 34
pro vyhledávání: '"A. P. Oksanich"'
Autor:
A. S. Oksanich, T. G. Samartseva, K. V. Kaa, E. V. Otrashevskaia, A. G. Krasko, A. G. Laputina, N. A. Netesova, G. M. Ignatyev
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 24, Iss 3, Pp 279-293 (2024)
INTRODUCTION. The completeness of virus inactivation and the identity of the vaccine strain are essential parameters for the safety and quality of inactivated virus vaccines, which should be controlled during vaccine development and production. Curre
Externí odkaz:
https://doaj.org/article/e4af3004a74a412b94cb3db07b5803cc
Autor:
N. A. Netesova, M. A. Abdurashitov, T. G. Samartseva, O. V. Klimovich, A. S. Oksanich, Е. V. Otrashevskaia, G. M. Ignatyev
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 24, Iss 3, Pp 270-278 (2024)
INTRODUCTION. Chikungunya virus (CHIKV) genotyping involves sequencing fractions of genes encoding E1, E2, and nsP1 proteins or the entire genome of the virus. Available reagent kits or polymerase chain reaction protocols cannot be used for CHIKV gen
Externí odkaz:
https://doaj.org/article/05fbe65f3d8846618b67160f30103918
Autor:
Elena V. Otrashevskaia, Konstantin V. Kaa, Alexey S. Oksanich, Nikita V. Murashko, Alexander G. Kusliy, Anatoliy G. Krasko, Vitaly V. Zverev, George M. Ignatyev
Publikováno v:
Журнал микробиологии, эпидемиологии и иммунобиологии, Vol 101, Iss 2, Pp 193-207 (2024)
Introduction. Chikungunya virus infection is a problem for the health care system of affected regions due to the lack of specific prevention, as well as effective antiviral drugs. The critical role of cellular immunity in viral control and clearance
Externí odkaz:
https://doaj.org/article/d8e29b512151446ebb778be1499f2240
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 23, Iss 4, Pp 544-559 (2023)
Scientific relevance. To date, no specific antivirals have been approved to treat and prevent Chikungunya fever, its complications, and sequelae. Therefore, the development of therapeutic and preventive medicinal products against Chikungunya virus (C
Externí odkaz:
https://doaj.org/article/cdde65c2928e4e5f922ab153eac6eb68
Publikováno v:
Elektrotehnìka ta Elektroenergetika, Vol 0, Iss 1 (2008)
В статті розглянуто основні динамічні показники малопотужних магнітоелектричних двигунів дискового типу. Отримано розрахункові форму
Externí odkaz:
https://doaj.org/article/9b3f48b75501453e8f672d96277252ca
Autor:
Georgy M. Ignatyev, Alexey S. Oksanich, Elena V. Kazakova, Tatyana G. Samartseva, Еlena V. Otrashevskaya, Stanislav V. Uyba, Victor P. Trukhin
Publikováno v:
Журнал микробиологии, эпидемиологии и иммунобиологии, Vol 100, Iss 5, Pp 310-318 (2023)
Introduction. The habitat of mosquitoes belonging to the genera Aedes spp., Culex spp., Culiseta spp. is in South and Central America, including Nicaragua. Monitoring of the spread of mosquito vectors and assessment of the infection with arboviruses
Externí odkaz:
https://doaj.org/article/7a59d174217641719d08f0141a62e800
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 22, Iss 4, Pp 405-413 (2022)
The severe consequences and high mortality of COVID-19 prompted the development of a wide range of preventive vaccines. The first vaccines to be tested were developed in China and formulated as inactivated SARS-CoV-2 adsorbed on aluminium hydroxide.
Externí odkaz:
https://doaj.org/article/46a8a117529a47f89b63ddcade4d2c17
Autor:
L. N. Lukhverchyk, G. L. Alatortseva, L. N. Nesterenko, V. Y. Kabargina, V. V. Dotsenko, I. I. Amiantova, O. B. Vylivannaya, A. V. Sidorov, A. V. Milovanova, O. S. Oksanich, S. Y. Konanykhina, V. V. Zverev
Publikováno v:
Эпидемиология и вакцинопрофилактика, Vol 20, Iss 6, Pp 72-80 (2022)
Relevance. The introduction of Varicella vaccine prophylaxis explains the need to develop a methodology for monitoring the vaccination effectiveness and the intensity of population immunity. This problem can be solved using quantitative immunoassay m
Externí odkaz:
https://doaj.org/article/e8e2f360c6994be7a3425bf2f3fc6307
Autor:
Ramil R. Mintaev, Dina V. Glazkova, Olga V. Orlova, Georgiy M. Ignatyev, Alexey S. Oksanich, German A. Shipulin, Elena V. Bogoslovskaya
Publikováno v:
Vaccines, Vol 11, Iss 4, p 831 (2023)
Dengue fever, an infectious disease that affects more than 100 million people every year, is a global health problem. Vaccination may be the most effective prevention strategy for the disease. However, the development of vaccines against dengue fever
Externí odkaz:
https://doaj.org/article/838f07486ccb48c085cc05bd64daf937
Autor:
G. M. Ignatyev, A. S. Oksanich, L. P. Antonova, T. G. Samartseva, S. V. Mosolova, K. M. Mefed, l. V. Gmyl, N. A. Netesova
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 20, Iss 2, Pp 107-115 (2020)
Rabies is an acute viral disease caused by a virus of the Rhabdoviridae family of the Lyssavirus genus, which affects the central nervous system and is characterised by absolute mortality. Vaccination is the only way to prevent the disease in humans.
Externí odkaz:
https://doaj.org/article/5a45e23d9a974b9e8d8fcf230bd11a20